1Debal V, Breillout F, Manfait M. Concomitant decrease of resistance and modifications of the cytoskeleton after all-trans retinoic acid and phorbol ester treatments in a navelbine-resistant bladder carcinoma cell line[J]. Anticancer Res, 1997,17(2A):1147-
2Fedoruk M N, Gimenez-Bonafe P, Guns E S, et al. P-glycoprotein increases the efflux of the androgen dihydrotestosterone and reduces androgen responsive gene activity in prostate tumor cells[J]. Prostate, 2004,59(1):77-90.
3VanBrussel J P, Jan VanSteenbrugge G, VanKrimpen C, et al. Expre-ssion of multidrug resistance related proteins and proliferative activity is increased in advanced clinical prostate cancer[J]. J Urol, 2001,165(1):130-135.
4David B G L, Overman M J, Petrofski J A, et al. Doxorubicin-resistant variants of human prostate cancer cell lines DU 145, PC-3, PPC-1, and TSU-PR1: characterization of biochemical determinants of antineoplastic drug sensitivity[J]. Int J Oncol, 2000,17(6
5Reinecke P, Schmitz M, Schneider E M, et al. Multidrug resistance phenotype and paclitaxel (Taxol) sensitivity in human renal carcinoma cell lines of different histologic types[J]. Cancer Invest, 2000,18(7):614-625.
6Vilenchik M, Raffo A J, Benimetskaya L, et al.Antisense RNA down-regulation of bcl-xL expression in prostate cancer cells leads to diminished rates of cellular proliferation and resistance to cytotoxic chemotherapeutic agents[J]. Cancer Res, 2002,62(7):21
7Tsuruo T, Iida H, Tsukagoshi S, et al. Overcoming of vin-cristine resis-tance in P388 leukemia in vivo and vitro through enhanced cytotoxicity of vincritine and vinblastine by verapamil[J]. Cancer Res, 1981,41: 1967-1971.
8Kim W J, Kakehi Y, Kinoshita H, et al. Expression patterns of multi-drug-resistance (mdr-1), multidrug resistance-associated protein (MRP), glutathione-S-transferase-pi (GST-π) and DNA topoisomerase II (Topo II) genes in renal cell carcinomas and normal
9Shi X B, Nesslinger N J, Deitch A D, et al. Complex functions of mutant p53 alleles from human prostate cancer[J]. Prostate, 2002,51(1):59-72.
10Eid H, Mingfang L, Institoris E, et al. MRP expression of testicular cancers and its clinical relevance[J]. Anticancer Res, 2000,20(5C):4019-4022.
